Table 2.
Comparison of antimicrobial resistance between E. coli and K. pneumoniae uncomplicated APNs
| E. coli (n = 372), N (%) | K. pneumoniae (n = 125), N (%) | p value | |
|---|---|---|---|
| Amikacin | 1 (0.3%) | 2 (1.6%) | 0.155 |
| Amoxicillin/clavulanate | 72 (29.1%) | 17 (22.6%) | 0.147 |
| Aztreonam | 127 (34.3%) | 39 (31.7%) | 0.005 |
| Cefazolin | 190 (51.2%) | 55 (44.7%) | 0.171 |
| Cefepime | 128 (34.5%) | 39 (31.7%) | 0.547 |
| Cefoxitin | 27 (6.0%) | 4 (3.3%) | 0.257 |
| Ceftazidime | 127 (34.2%) | 41 (33.3%) | 0.855 |
| Ciprofloxacin | 162 (43.7%) | 41 (33.3%) | 0.034 |
| Ertapenem | 0 (0.0%) | 4 (3.3%) | 0.004* |
| Gentamicin | 111 (29.9%) | 27 (21.9%) | 0.075 |
| Imipenem | 0 (0.0%) | 4 (3.3%) | 0.004* |
| Piperacillin/tazobactam | 19 (5.1%) | 19 (15.4%) | < 0.001 |
| TMP/SMX | 151 (40.7%) | 40 (32.5%) | 0.106 |
| ESBL | 127 (34.2%) | 35 (28.5%) | 0.237 |
*Fisher’s exact test
TMP/SMX trimethoprim/sulfamethoxazole, ESBL extended-spectrum beta-lactamase